Skip to main content

Advertisement

SpringerLink
Log in

Antibacterial envelope use to prevent cardiac implantable device infection: outcomes from the national readmission database

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device Infection undergoing transvenous lead extraction: the impact of the Infection type and the presence of vegetation on survival. Europace Oct. 2014;16:1490–5.

    Article  Google Scholar 

  2. Dai M, Cai C, Vaibhav V, et al. Trends of Cardiovascular Implantable Electronic Device Infection in 3 decades: a Population-based study. JACC Clin Electrophysiol Sep. 2019;5:1071–80.

    Article  Google Scholar 

  3. Krahn AD, Longtin Y, Philippon F, et al. Prevention of Arrhythmia device Infection trial: the PADIT Trial. J Am Coll Cardiol Dec. 2018;18:72:3098–109.

    Article  Google Scholar 

  4. Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent Cardiac Implantable device Infection. N Engl J Med May. 2019;16:380:1895–905.

    Article  Google Scholar 

  5. Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with Infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation Sep. 2014;23:130:1037–43.

    Article  Google Scholar 

  6. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the Infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol Aug. 2011;30:58:1001–6.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Islam Shatla and Nikhil A Mehta contributed equally to the preparation of the manuscript.

Authors and Affiliations

  1. Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, USA

    Islam Shatla

  2. Division of Cardiovascular Disease, Saint Luke’s Mid America Heart Institute, 4330 Wornall Rd, Ste 2000, Kansas City, MO, 64111, USA

    Nikhil A. Mehta, Kevin F. Kennedy & Alan P. Wimmer

  3. Division of Cardiovascular Disease, Loyola University Medical Center, Loyola Stritch School of Medicine, Maywood, IL, USA

    Ahmed Elkaryoni

Authors
  1. Islam Shatla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikhil A. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin F. Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed Elkaryoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alan P. Wimmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan P. Wimmer.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shatla, I., Mehta, N.A., Kennedy, K.F. et al. Antibacterial envelope use to prevent cardiac implantable device infection: outcomes from the national readmission database. J Interv Card Electrophysiol (2023). https://doi.org/10.1007/s10840-023-01715-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10840-023-01715-5

Search

Navigation